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Parkinson’s disease (PD) is classically characterized by motor symptoms; however,
non-motor symptoms (NMS) are increasingly recognized as relevant in disease-state,
given the associated alterations in mood (depression and anxiety) and cognition. Here,
particularly in regards to NMS, we aimed to compare the motor, emotional and cognitive
behavior of three animal models of PD that trigger dopaminergic (DAergic) degeneration
on both brain hemispheres: (i) the 6-hydroxydopamine (6-OHDA, 8 or 6μg) lesion model;
(ii) the paraquat (PQ) induced model, and (iii) a genetic model based on α-synuclein
overexpression (α-syn). 6-OHDA and α-syn vector were injected bilaterally in the substantia
nigra pars compacta (SNpc) of adult male Wistar rats; as for PQ delivery, micro-osmotic
pumps were implanted in the interscapular region. Motor deficits were observed in
all models, with histological analysis of tyrosine hydroxylase positive cells in the SNpc
revealing a significant loss of DAergic neurons in all animal models. In addition, the α-
syn animal model also presented a reduction in exploratory activity, and the 6-OHDA
and PQ animals displayed a significant increase in both depressive- and anxiety-like
behavior. Interestingly, cognitive impairment (working memory) was only observed in
the 6-OHDA model. Overall, these PD models are suitable for mimicking the motor
symptoms associated to PD, with each encompassing other relevant NMS components
of the disorder that may prove beneficial for further studies in PD.
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INTRODUCTION
Parkinson’s disease (PD), one of the most frequent neurode-
generative disorders, is characterized by the progressive loss of
dopamine (DA) neurons in the substantia nigra pars compacta
(SNpc), leading to striatal DA depletion. This degeneration of
DAergic nigrostriatal system is largely responsible for the classi-
cal motor signs, including: resting tremor, muscle rigidity, and
bradykinesia (Fearnley and Lees, 1991; Olanow and Tatton, 1999).
Furthermore, non-motor symptoms (NMS) are also becoming
increasingly recognized as relevant symptoms in PD patients
(Langston, 2006; Chaudhuri and Schapira, 2009); however, these
are still frequently undiagnosed and, therefore, left untreated
(McDowell and Chesselet, 2012).
Of particular concern, NMS can include emotional and cog-
nitive deficits, sleep disorders, and autonomic, gastrointestinal,
and sensory dysfunction (Chaudhuri and Schapira, 2009). In
fact, depression is one of the most frequently encountered psy-
chiatric problems in PD patients and can appear early in the
progression of the disease (Aarsland et al., 2012). Anxiety may
also be a comorbidity for PD patients, affecting up to 40% of
individuals, sometimes in association with depression (Walsh and
Bennett, 2001; Martinez-Martin and Damian, 2010). Relevant,
these neuropsychiatric alterations are often accompanied by cog-
nitive impairments, which can occur in the early stages of the
disease. However, of note, this cognitive “dysfunction” is more
common in older patients with advanced PD, among whom
dementia can affect up to approximately 24–31% of patients
(Aarsland et al., 2005; Chaudhuri and Schapira, 2009; Kehagia
et al., 2010).
In this context, taking into account the influence of the NMS
in the quality of life of PD patients, it is of interest to assess
whether NMS can also be studied in animal models of PD. The 6-
hydroxydopamine (6-OHDA) rat model has been the most exten-
sively studied animal model of PD, including results from our
group indicating that the unilateral 6-OHDA-lesion in the medial
forebrain bundle is a suitable model to investigate depressive-like
behavior and exploratory activity impairments associated with
PD (Carvalho et al., 2013). Usually 6-OHDA is administrated
unilaterally, leading to an asymmetric motor behavior that can
be quantified and correlated with the degree of lesion; however,
bilateral models mimic more closely the condition in humans
(Deumens et al., 2002). Few studies have used bilateral injections
of 6-OHDA in the striatum, and the available results are quite
conflicting. For instance, while one study showed that injured ani-
mals presented a depressive-like state, a decrease in anxiety-like
behavior and alterations in social behavior without changes in
cognitive functions (Branchi et al., 2008), another study reported
that a similar lesion led to the development of cognitive deficits as
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well as a depressive and anxious-like state (Tadaiesky et al., 2008).
There are also reports indicating that rats injected bilaterally in
the SNpc also present alterations in depressive-like behavior and
in cognitive performance tasks (Ferro et al., 2005; Santiago et al.,
2010).
Furthermore, as several epidemiological studies have reported
that exposure to environmental toxins, such as herbicides, results
in an increased risk of PD (McCormack et al., 2002), studies in
rodents have also been performed to assess if herbicides, such as
paraquat (PQ), rotenone, andmaneb, are able to reproduce classi-
cal features of the disease. However, the ability of these models to
mimic NMS has been less explored and to the best of our knowl-
edge there is only one report showing that mice treated with PQ
develop an anxiety-like state (Litteljohn et al., 2008). Again, the
possibility of using this model to study NMS of PD remains to be
determined.
Finally, genetic models of PD are more recent and have been
largely focused on overexpression of wild-type (wt) or mutated
α-synuclein (α-syn) in transgenic mice. In spite of providing a
suitable model to study the involvement of α-syn in PD patho-
genesis, this model present several limitations. In fact, none of
the transgenic α-syn mouse models presented the key features of
the disease, namely the extensive nigrostriatal DAergic degenera-
tion or the motor impairments (Magen and Chesselet, 2010). An
alternative to these transgenic models is the use of viral vectors
to promote the overexpression of α-syn specifically in the nigros-
triatal system. The ability of such approach to reproduce many
features of the disease, such as the progressive and severe degen-
eration of the nigrostriatal pathway and motor abnormalities, has
proved successful in some studies (Kirik et al., 2002; Decressac
et al., 2012a,b); yet, NMS have never been investigated in this
model.
Theaimof thecurrent studywas touse threedifferent ratmodels
of PD (6-OHDA, PQ administration, and adeno-associated virus
(AAV)-mediated overexpression of α-syn) to assess emotional
and cognitive behaviors, in parallel with motor performance.
This phenotypic characterization was complemented with the
immunohistological evaluation of the nigrostriatal lesion.
MATERIALS AND METHODS
ANIMALS AND EXPERIMENTAL PROTOCOL
Experiments were conducted in accordance with the national eth-
ical requirements for animal research, and with the European
Convention for the Protection of Vertebrate Animals Used for
Experimental and Other Scientific Purposes. Young adult male
Wistar rats (Charles River, Barcelona, Spain) weighing 300–350 g
at the beginning of the experiments, were housed in pairs, in
appropriate cages, under standard controlled conditions (12 h
light/12 h dark cycle; room temperature 22◦C; food and water
freely available). After surgeries, the animals were allowed to
recover for 5 weeks before starting the behavioral assessment.
Starting in the sixth week after surgery, all animals were exposed
to the following sequential behavioral tests: elevated-plus maze
followed by the forced swimming test (both performed in the
sixth week), Morris water maze (seventh and eighth weeks),
rotarod followed by open field and the sucrose preference test
(all in week 10), and the skilled paw reaching test (week 11).
The minimum interval between two consecutive procedures was
2 days. All animals were subjected to the same sequence of behav-
ioral test and sacrificed 12 weeks after surgery. Rats were deeply
anesthetized with pentobarbital and were transcardially perfused
with 4% paraformaldehyde (PFA) in PBS. The brain was then
removed surgically for immunohistochemistry (IHC) analysis.
6-OHDA OR AAV α-SYN INJECTION IN THE SUBSTANTIA NIGRA
Under ketamine and medetomidine (75mg/kg: 0.5mg/kg, i.p.)
anesthesia, the animals were placed on a stereotaxic frame.
Animals were pre-treated with desipramine (25mg/kg) 30min
prior to 6-OHDA injection in order to protect noradrenergic neu-
rons. Bilateral injections of 8 or 6μg of 6-OHDA (dissolved in
2μl of 0.2% ascorbic acid saline solution) were performed in
the SNpc [coordinates with respect to bregma: A −5.3; L ±1.8;
V −7.4mm according to the stereotaxic atlas of Paxinos and
Watson (1998)] by means of a 10μl Hamilton syringe. A differ-
ent group of animals was also injected stereotaxically using the
same protocol with 2μl of AAV serotype 2 (AAV2) to selectively
overexpress human α-syn. Control (sham) animals received the
same volume of vehicle, following the same procedure. The solu-
tions were infused at a rate of 0.5μl/min and after the injection
the needle was left in place for an additional 2min period before
it was slowly retracted.
IMPLANTATION OF PARAQUAT (PQ) MINI-OSMOTIC PUMPS
Under anesthesia with ketamine and medetomidine animals
were implanted with Alzet mini-osmotic pumps (Model 2004,
Durect™) delivering for 28 days at a rate of 0.7 mg/day PQ
(Sigma). Implants were placed in the subscapular region.
CONSTRUCTION OF HUMAN α-SYNUCLEIN DELIVERY VECTOR
U6-CMV-EGFP/pAAV (AAV-α-syn) AND PREPARATION OF rAAV2
CONTAINING a-syn
U6 promoter-driven α-syn expression system was established in
AAV2 vector, with EGFP expression separately controlled by a
CMV promoter as a marker for the transduction efficiency. The
plasmid DNA vector only or AAV2-α-syn were co-transfected
with plasmids pHelper and pAAV-RC to HEK293 AAV cells using
a standard calcium phosphate method. At 72 h post-transfection,
the cells were harvested and crude rAAV vector solutions were
obtained by repeated freeze/thaw cycles. The cleared crude
lysate was applied on a heparin column. After the total lysate
passed through the column, the matrix was washed twice with
25ml of PBS with low NaCl (pH7.4, 0.1M NaCl) and the
virus eluted with 15ml of PBS with high NaCl (PBS; pH 7.4,
0.4M NaCl). The elute was concentrated to about 1ml using
a Millipore Biomax-100K NMWL filter device (UFV2BHK40)
by centrifugation at 4000 rpm, 15–40min. To adjust the NaCl
concentration to physiological levels, the filter device was refilled
with PBS (pH 7.4) and the virus concentrated to 250–300μl.
After removal of the virus-containing solution, the membrane
of the filter device was washed three times with PBS (pH 7.4)
that was added to the main part of the recombinant AAV2. The
fractions containing high-titer rAAV vectors were collected and
used for injection into animals. The number of rAAV genome
copies was semi-quantified by PCR within the CMV promoter
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region using primers 5′-GACGTCAATAATGACGTATG-3′
and 5′-GGTAATAGCGATGACTAATACG-3′. The final titers
were 6.4 × 1011 genomes/μl (rAAV2-vector) and 5.5 × 1011
genomes/μl (rAAV2-α-syn). Each animal received 11 × 1011
genomes of the respective rAAV-vector.
BEHAVIORAL ASSESSMENT
Elevated plus maze
Anxiety-like behavior was measured in the elevated plus maze as
previously described (Pego et al., 2008). The apparatus comprised
two open arms (50.8 × 12 cm) and two closed arms (50.8 × 12 ×
40.6 cm) that extended form a common central platform (10 ×
10 cm), raised 72.4 cm above the floor. Each animal was indi-
vidually placed in the central platform facing the open arm and
allowed to explore themaze freely for 5min. After each session the
apparatus was cleaned with 10% ethanol. The test was recorded
via a video camera and the behavioral analysis was carried out
using The Observer Basic 3.0 software. The behavioral parame-
ters recorded were: number of entries into the open and closed
arms; and, percentage of time spent in the open and closed arms,
and at the arms intersection. Percentage of time spent in the open
arms was used as an index of anxiety-like behavior, whereas the
number of entries in closed arms was taken as a measure of loco-
motor activity, which is considered more valid than total number
of arms entries (Wall and Messier, 2001).
Forced swim test
The forced swim test was used to evaluate depressive-like behav-
ior, as previously described (Leite-Almeida et al., 2009). Rats were
placed in a cylinder filled with water (24◦C), for a period of
5min. The test was recorded via a video camera and latency to
stop and immobility time were determined. Depressive-like state
was defined as an increase in time of immobility and decrease in
latency to immobility.
Morris water maze
Cognitive function was assessed in the Morris Water Maze test,
which is composed by working memory, spatial reference mem-
ory, and reversal learning tasks. The tasks were performed essen-
tially as described by Cerqueira et al. (2007). Briefly, the tests were
made in a circular black tank (170 cm diameter), filled with water
at 24◦C to a depth of 31 cm in a dimly illuminated room with
extrinsic spatial clues on the walls. The tank was divided in imag-
inary quadrants and had an invisible platform placed within one
of them. Data were collected using a video camera fixed on the
ceiling, above the center of the tank and connected to a video-
tracking system (View Track v.2.6., ViewPoint Life Sciences Inc.).
The position of the platform varied according to each task. In each
day of test, animals performed four trials to find the platform. At
the beginning of each trial, animals were placed in the periphery
of the selected quadrant facing the wall of the maze. Trials were
automatically ended once the animals reached the platform; if the
animal failed to find the platform in 120 s, it was gently guided
to it. Between each trial the animals were allowed to rest in the
platform for 20 s. Time to reach the platform and the distance
traveled were automatically recorded. The working memory task
measures the capacity to learn the location of the platform and to
retain this information during four consecutive trials. This task
was conducted during 4 days, throughout which the platform
was hidden in a different position each day. The last day of the
working memory task corresponded to the first day of the spa-
tial reference memory task, which was designed to evaluate the
ability to learn the position of the platform during three consec-
utive days. The platform remained in the same position (“old”
quadrant) throughout the 3 days. The reversal learning task was
performed on the seventh day, assessing for cognitive flexibility.
During the task, the platform was positioned on the opposite
quadrant (“new” quadrant) of the last 3 days and animals were
similarly tested during four trials. On this last day of the test a
fifth trial was added, the probe trial, in which the platform was
removed from the tank and each animal was tested for a 120 s
period. The distance swum in each quadrant was recorded in all
five trials.
Rotarod
The motor performance was performed at 8 weeks post-surgery
using the rotarod equipment (3376O4R, TSE Systems) as pre-
viously described (Monville et al., 2006). The unit consists of
a rotating spindle, a power source for turning the spindle and
grids beneath the rotating roller where the rat can fall without
injury. All animals were pre-trained on the rotarod apparatus in
order to reach a stable performance. The training consisted of
four sessions on 3 consecutive days, under an accelerating pro-
tocol starting at 4 rpm and reaching 40 rpm in 5min; each session
included three separate trials, with at least 20min of rest between
trials. At the fourth day the final test was performed under the
same accelerating protocol and the latency to fall was recorded.
Sucrose preference test
Anhedonia was assessed using the sucrose preference test pre-
viously described by Carvalho et al. (2013). The test consisted
of depriving animals food and water for 18 h and afterwards
presenting two preweighted (separate) bottles, one containing
3% sucrose solution and a second containing tap water, during
1 h. Sucrose preference was calculated according to the formula:
sucrose preference = (sucrose intake/(sucrose intake + water
intake)) × 100. Reduced sucrose preference is suggestive of anhe-
donia and thus of depression-like behavior. In addition, we also
analyzed the total sucrose and water consumption to compare
general fluid intake between the groups.
Open field
The open field was used to assess locomotor behavior as previ-
ously described (Leite-Almeida et al., 2009). The rat was placed
in the center of a square (43.2 cm × 43.2 cm) arena (ENV-515,
Med Associates Inc.) and allowed to explore the arena for 5min.
With the help of the tracking software (SOF-811, Med Associates
Inc.) total distance traveled, time in rest, number of rearings and
ambulatory episodes were recorded. The arena was cleaned with
10% ethanol between each animal.
Skilled paw reaching test
Skilled paw reaching was assessed using a double staircase box
(80300, Campden Instruments Ltd.); shape and dimensions were
similar to the device described by Montoya et al. (1991). The
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apparatus was developed to assess the independent forelimb use
in skilled reaching and grasping task. Briefly, the apparatus con-
sists of a clear chamber with a hinged lid. A narrow compartment,
with a central platform running along its length, is connected to
this chamber. A removable double staircase with 7 steps on each
side can be inserted in the space between the platform and the box
walls. Three pellets were placed into each well of the double stair-
case apparatus. In the first 2 days, the rats were familiarized with
the test, with the pellets being available for 5 and 10min, respec-
tively. In the test session, the animals were placed inside the box
and had 15min to reach, retrieve, and eat the food pellets placed
on the steps. All sessions were performed at the same time of the
day and with food restricted animals. After the period test, the
animals were removed from the box and the remaining (left over)
pellets counted.
IMMUNOHISTOCHEMISTRY
IHC was carried out in free-floating mesencephalic axial frozen
sections (35μm). The chromogenic IHC assay was used to detect
DAergic neurons. Nonspecific antibody binding was blocked by
incubation for 60min in PBS with 10% FCS containing 0.1%
Triton X-100. Endogenous peroxidase activity was quenched by
10min incubation in 1% H2O2. Sections were incubated with
mouse anti-tyrosine hydroxylase (TH) (1:1000; Transduction
Laboratories) diluted in PBS with 1% FCS. Incubations with the
primary antibodies were performed overnight at 4◦C. Sections
were then incubated for 1 h at room temperature with biotiny-
lated secondary antibody, goat anti-mouse IgG (1:200; Vector
Laboratories), diluted in PBS. After that sections were incubated
with avidin peroxidase (1:1000 in PBS; Vector Laboratories) for
50min at room temperature. The reaction product was visual-
ized using diaminobenzidine (DAB, Sigma) in TBS with 0.0024%
H2O2.
QUANTITATIVE ANALYSIS OF TH POSITIVE CELLS
The immunohistochemically processed sections were used to
evaluate the total number of TH immunoreactive cells within the
SNpc. On mesencephalic sections, the region comprising the TH
positive cells, correspondent to SNpc, was delineated and the total
number of TH positive cells was counted in the full extent of
the structure per section. Every sixth section covering the entire
extent of the SNpc was included in the counting procedure. The
following formula was used to estimate the number of TH neu-
rons: N = V(SNpc) (Q/V(sect)); where N is the estimation
of cell number, V is the total volume of SNpc, Q is the total
number of cells counted in the sections, and V(sect) is the total
volume of counted sections.
STATISTICAL ANALYSIS
All data sets were tested for normality distribution with the
Shapiro–Wilk test prior to any statistical analysis. Data are
expressed as mean ± standard error of mean (s.e.m.). Statistical
analysis was performed using Student t-test, Mann–Whitney
nonparametric test, one-way or repeated measures analysis of
variance (ANOVA), as appropriate. Differences between groups
were further analyzed by Dunnett’s or Bonferroni’s post tests.
p-value of 0.05 was considered statistically significant. All statisti-
cal procedures were performed using GraphPad Prism, version 4
(GraphPad Software Inc., San Diego, CA, USA).
RESULTS
ASSESSMENT OF THE EXTENT OF THE LESION
Histological analysis of TH positive cells in the SNpc revealed
a significant loss of DAergic neurons in all the animal models
(Figure 1). The highest difference [F(2.11) = 15.32; p = 0.0007]
was observed in 6-OHDAmodel, when compared with sham rats,
with post-hoc analysis showing a marked decrease in the num-
ber of TH positive cells in the SNpc of animals treated with both
8 and 6μg of 6-OHDA (43.04 ± 4.673% and 47.08 ± 4.819%,
respectively). In the PQ-exposed rats a 39% reduction of nigral
DAergic neurons was also observed (U = 0.0; p = 0.0022). The
less severe lesion (21%) was induced by the overexpression of
α-syn (U = 6.0; p = 0.02).
MOTOR PERFORMANCE
General motor performance was assessed at 8 weeks after surg-
eries, using the accelerating rotarod test. Animals in all PDmodels
displayed significant reductions in the latency to fall [t = 3.498
for PQ; U = 172.0 for α-syn; F(2.41) = 6.726 for 6-OHDA; all
p < 0.01] (Figure 2).
The skilled paw reaching test was use to assess forelimb use;
this test was performed 10 weeks post-lesion and the num-
ber of pellets eaten was evaluated. Regarding the PQ model,
ANOVA showed an effect for the factor time [F(3.45) = 29.17;
p < 0.001], but no effect for the factor lesion [F(1.45) = 4.526;
p = 0.0504], as well as no interaction between these factors
[F(3.45) = 0.3662; p = 0.777] (Figure 3A). In the α-syn model, a
significant effect of time [F(3.84) = 21.66; p < 0.0001] and lesion
[F(1.84) = 2.871;p = 0.1013]wasverified,whilenointeractionwas
detected between these two factors [F(3.84) = 0.6312; p = 0.5969]
(Figure 3B). Similar results were obtained in rats injected with 6-
OHDA,withasignificanteffectoftime[F(3.57) = 23.42;p < 0.001]
and lesion [F(2.57) = 4.363; p = 0.0276], without interaction
between the factors [F(6.57) = 1.136; p = 0.3533] (Figure 3C).
FIGURE 1 | Dopaminergic cell loss induced by PQ, α-syn
overexpression and 6-OHDA. Eleven weeks after lesion, the animals were
sacrificed and the substantia nigra region was processed for tyrosine
hydroxylase (TH) immunohistochemistry (A). Representative
photomicrographs of midbrain sections immunostained for TH are
presented in (B). Data are expressed as the percentage of control animals
and represent the mean ± s.e.m. of at least five animals per group.
∗P < 0.05 and ∗∗P < 0.01 compared to control.
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FIGURE 2 | Motor performance of PQ (A), α-syn (B) or 6-OHDA (C) treated animals measured as latency to fall in accelerating rotarod test. Data are
presented as mean ± s.e.m. ∗∗p < 0.01.
FIGURE 3 | Effects of PQ delivery (A), α-syn overexpression (B) or 6-OHDA injection (C) on paw reaching performance. Performance of rats in the paw
reaching test is expressed as mean ± s.e.m. number of eaten pellets. ∗p < 0.05 and ∗∗p < 0.01.
Post-hoc testing revealed decreased success in the number of eaten
pellets in rats treated with 6-OHDA high dose in comparison to
sham, at day 3 and 4 (p < 0.05 and p < 0.01, respectively).
EXPLORATORY AND LOCOMOTOR ACTIVITY
The open field was the test was to used to assess exploratory activ-
ity; the test was carried out at 9 weeks post-surgery. Exploratory
activity did not differ between sham and PQ rats, with no
differences found in the total distance traveled (U = 548.398;
p = 0.6334), number of ambulatory episodes (U = 200.0; p =
0.5008), and number of rearings (t = 0.2845; p = 0.7775)
(Figures 4A,D,G,J). Overexpression of α-syn resulted in a
decrease in the total distance traveled (U = 113.0; p < 0.0001)
accompanied by an increase in the rest time. Significant dif-
ferences were also observed regarding the number of ambula-
tory episodes, with α-syn rats presenting lower number when
compared with sham animals (t = 3.242; p = 0.0020), and the
number of rearings was also decreased (U = 57.5; p = 0.0333)
(Figures 4B,E,H,K). Finally, an overall effect was found on the
total distance traveled in 6-OHDA lesioned rats [F(2.46) = 3.34;
p = 0.0442]. A post-hoc comparison revealed that animals treated
with 6-OHDA 8μg traveled significantly less than sham rats. In
contrast, 6-OHDA 6μg rats traveled a total distance that did not
differ from that observed in the sham group. No differences were
observed in ambulatory episodes [F(2.48) = 1.595; p = 0.2134]
and in number of rearings [F(2.47) = 2.061; p = 0.1387], in both
6-OHDA doses (Figures 4C,F,I,L).
ANXIETY-LIKE BEHAVIOR
The elevated plus maze was used to assess for anxious-like
behavior. Data showed that both PQ and 6-OHDA lesions
affected anxiety-like behavior. Specifically, regarding the percent-
age of time spent on the open arms, treated animals from these
groups spent less time in the open arms when compared to
sham animals [U = 24.50, p < 0.0001 for PQ; F(2.38) = 5.203,
p = 0.0101 for 6-OHDA] (Figures 5A,C). The same tendency was
verified for α-syn rats, but no statistical significant differences
were found (U = 222.0; p = 0.1882) (Figure 5B). No statistically
significant differences were found in the number of entries on the
closed arms in any of the lesion models [U = 150.0, p = 0.0914
for PQ; U = 268.0, p = 0.1945 for α-syn; F(2.48) = 1.799, p =
0.1765 for 6-OHDA] (Figures 5D–F).
DEPRESSIVE-LIKE BEHAVIOR
Forced swimming test was used to assess depressive-like behav-
ior; in addition, sucrose preference test was conducted to evaluate
for anhedonia. PQ delivery and bilateral 6-OHDA injection in the
SNpc significantly affected behavioral response in latency to stop
[U = 70.0, p = 0.0028 and F(2.34) = 6.658, p = 0.0036, respec-
tively] (Figures 6A,C). Post-hoc tests revealed that latency to stop
time was shorter in 6-OHDA animals treated with either of the
6-OHDA doses, when compared to the sham rats, although this
difference was more pronounced with the lower dose (p < 0.05
for 6-OHDA 8μg; p < 0.005 for 6-OHDA 6μg). Total immobil-
ity time was, however, only affected in the PQmodel (U = 121.0,
p = 0.0290) and not in the 6-OHDA model [F(2.47) = 0.3016,
p = 0.741] (Figures 6D,F). In α-syn model no differences were
found (latency to stop: U = 356.5, p = 0.7283; immobility: U =
290.0, p = 0.1128) (Figures 6B,E).
Regarding sucrose preference no differences were observed
in all the PD models studied [U = 141.0, p = 0.1162 for PQ;
U = 385.0, p = 0.9613 for α-syn; F(2.44) = 1.786, p = 0.1795 for
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2013 | Volume 7 | Article 175 | 5
Campos et al. PD models: non-motor symptomatology
FIGURE 4 | Locomotory and exploratory activity. Differences in total distance traveled (A–C), time in rest (D–F), number of ambulatory episodes (G–I) and
number of rearings (J–L). Data expressed as mean ± s.e.m. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
6-OHDA] (Figures 6G–I). Nevertheless, in animals injected with
6-OHDA (at both doses) a trend for decreased preference for
sucrose was observed.
In addition, the different lesions did not significantly affect the
total amounts of sucrose and water intake (Figures 6J–L).
COGNITIVE PERFORMANCE
The Morris water maze was performed to evaluate cognitive
functions. The protocol was divided in three different tasks to
investigate both working and spatial reference memories and cog-
nitive flexibility. No interaction between lesion and time were
found in PQ and α-syn models in any of the tasks (all F-values >
0.2635, all p-values> 0.0714) (Figures 7A,B,D,E,G,H). However,
in the 6-OHDAmodel, escape latency analysis ofworkingmemory
revealed a significant interaction between lesion and daily perfor-
mance [F(6.144) = 2.25;p = 0.0417] anda significant effect of time
[F(3.144) = 18.95; p < 0.001] (Figure 7C). Post-hoc comparison
revealed an improvement in daily performance in the sham group
(all p-values < 0.001, for each day as compared to the first day),
which was not observed in 6-OHDA rats. In high dose of 6-OHDA
the improvements were observed between the first and second,
and first and fourth days (p < 0.001 and p < 0.01, respectively)
whereas there was no difference between first and third day. Rats
injected with low 6-OHDA dose only improved the performance
betweenfirst and thirdday (p < 0.05). In the other tasks the escape
latency and distance swam did not differ between the groups (all
F-values > 0.4394, all p-values > 0.743) (Figures 7F,I).
DISCUSSION
The present work confirmed that all three animal models of PD
trigger the characteristic motor symptoms of the disease, as a
consequence of reduced number of TH-positive neurons in the
SNpc. Furthermore, on the latter parameter, we found a range of
variation from 20 to almost 50% in the reduction of TH-positive
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FIGURE 5 | Anxiety-like behavior in the elevated-plus maze. Data on percentage of time in open arms (A–C), and number of entries in closed arms (D–F).
Data expressed as mean ± s.e.m. ∗p < 0.05 and ∗∗∗p < 0.001.
cells, which is within the ranges of variance observed in other
studies using similar animals models (Kirik et al., 2002; Pioli
et al., 2004; Cristovao et al., 2009, 2012; Decressac et al., 2012b).
However, we failed to find a significant correlation between the
DAergic neuronal degeneration and the severity of the motor
deficits; therefore, we cannot make an association between each
model and a stage of the disease progression, as have been done
in other studies.
The main goal of this study was, however, to characterize the
NMS in each of these animal models. First, it is relevant to high-
light, here animal models that triggered DAergic degeneration on
both hemispheres were chosen, which is of importance to the
emergence of the full spectrum of behavioral symptoms of the
disease. Briefly, from analysis of an extensive battery of behav-
ioral tests, the PQ, the 6-OHDA and the α-syn models of PD were
shown to have distinctive patterns of NMS impairments.
EFFECTS OF PQ INDUCED LESION
The use of the herbicide PQ to study PD and NMS is still emerg-
ing. In contrast, the study of motor deficits in this model has
already been done both in rats (Somayajulu-Nitu et al., 2009)
and mice (Litteljohn et al., 2008). Herein we confirmed the exis-
tence of deficits in the motor performance of PQ-exposed rats;
however, impairments were visible on the rotarod, but not in
the skilled paw-reaching test. These results suggest that, in spite
of the global motor coordination deficits produced by PQ, these
animals presented normal fine motor control. Furthermore, the
present study also indicated non-motor alterations in this model
of PD. In particular, PQ treated rats spent less time in open arms
in the elevated plus maze; this difference cannot be ascribed to
motor deficits as the number of closed arms entries was simi-
lar in PQ and sham rats. Therefore, and in contrast to previous
observations in mice (Litteljohn et al., 2008), these findings
demonstrate that PQ induces anxious-like symptoms in rats. As to
depressive-like behavior, we found that PQ treated rats displayed
increased immobility, as well as a decreased latency to stop in
forced swimming test, but no changes in anhedonic behavior. As
the latter test is less dependent on locomotion, the former changes
must be regarded with caution. Finally, nomajor cognitive deficits
were found in PQ treated rats. The lack of deficits in these behav-
ioral domains merits to be highlighted as it is known that PQ not
only affects the nigrostriatal pathway but also accumulates in the
cortex and in the hippocampus (Prasad et al., 2009), with one
study revealing the ability of PQ to exacerbate cognitive impair-
ments in an Alzheimer’s disease model (Chen et al., 2012). We
can hypothesize that our low-dose chronic PQ infusion regimen
was not enough to accumulate in these brain regions and to cause
significant deficits in the tasks we assessed, since the classic PQ
rodents models of PD used in previous studies are achieved by
exposure to higher doses of PQ.
EFFECTS OF α-SYN OVEREXPRESSION
Injection of viral vectors in the SNpc, to promote the overexpres-
sion of wt or mutated human α-syn, has recently proved to be a
promising model of PD. Confirming previous studies (Decressac
et al., 2012b), the animals injected with AAV2-α-syn vector pre-
sented a reduction in locomotor activity measured in the rotarod,
even though it was associated with a less striking neuronal loss in
the SNpc. Interestingly, in comparison with the other two mod-
els herein studied, this approach was the poorest regarding NMS.
In fact, only a decreased exploratory activity in the open field test
was observed. Otherwise, no significant changes were observed
in anxiety- and depressive-like behaviors, and their learning and
memory abilities seemed to be unaffected by the overexpres-
sion of α-syn (a similar phenotype to the one observed in PQ
model). These results seem to be contradictory with previous
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FIGURE 6 | Forced swimming test (A–F) for depressive-like behavior.
Data regarding latency to immobility (A–C) and immobility time (D–F).
Presence of anhedonia, assessed through the sucrose preference test
(G–I). Total sucrose and water consumption during the sucrose
preference test (J–L). Data expressed as mean ± s.e.m. ∗p < 0.05 and
∗∗p < 0.01.
reports using α-syn models, namely at the cognitive performance
level (Freichel et al., 2007; Masliah et al., 2011; Magen et al.,
2012). It is, however, important to note that previous studies
assessing NMS in α-syn models have been performed in trans-
genic mice in which α-syn aggregates are distributed through the
cortex and hippocampus similar to what has been described in
PD with dementia (Churchyard and Lees, 1997; Hurtig et al.,
2000).
EFFECTS OF 6-OHDA LESION
The most widely used model of PD consists in the injection
of 6-OHDA into one of the following three target sites: SNpc,
medial forebrain bundle or the caudate-putamen. In spite of
being the most scrutinized, including NMS, there is still a
lack of studies using the bilateral 6-OHDA lesion model. Here,
rats injected with two doses of 6-OHDA, bilaterally into the
SNpc, displayed motor deficits accompanied by several NMS;
the latter including increased anxious and depressive-like behav-
iors, and working memory deficits. Surprisingly, no differences
were observed between the two doses of 6-OHDA, suggesting that
lower dose is sufficient to produce all the effects observed, being
in accordance with the similar impact that both doses had on
DAergic neurons degeneration.
More specifically, the motor performance, assessed through
the rotarod and skilled paw-reaching test, was clearly impaired.
Motor abnormalities were also observed in the open field test,
where 6-OHDA animals treated with higher dose displayed a
shorter travel distance. In the elevated plus maze test, 6-OHDA
treated animals showed a significant decrease in time spent
in the open arms, while no differences in closed arms were
observed, thus suggesting an anxious-like state in these animals.
The anxious phenotype is in line with observations showing that
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FIGURE 7 | Cognitive behaviors. Animals were challenged with three
tasks that differed in their cognitive requirements. Working memory
performances of sham and injured animals are compared, PQ (A), α-syn
(B) and 6-OHDA (C) animals. Similarly, spatial reference memory
performance is plotted in graphs (D–F) and reversal learn task
performances (G–I). The four quadrants of the pool are assigned with
letters N, E, S, W; the actual and the former platform positions are,
respectively, N and S. ∗p < 0.05.
infusion of 6-OHDA in the striatum also results in an increase
in anxiety-like behavior (Tadaiesky et al., 2008). Regarding mood
behavior, previous studies reported an increase in depressive-
like behavior after bilateral 6-OHDA into the SNpc or striatum,
assessed both by sucrose preference test and forced swimming test
(Branchi et al., 2008; Santiago et al., 2010). Although, no signifi-
cant effect was found in the sucrose preference test, the tendency
to an anhedonic behavior in lesioned rats, herein observed, was
reinforced by a shorter latency to immobility in forced swimming
test. This may suggest a predisposition to a depressive phenotype
induced by bilateral 6-OHDA lesion. Noticeably, this was the only
model presenting cognitive deficits as measured by differences
in working memory performance, a task highly dependent on
DA levels in the prefrontal cortex (D’Hooge and De Deyn, 2001;
Cerqueira et al., 2007).
CONCLUDING REMARKS
In conclusion, here the data demonstrates that all the mod-
els included in this study present the crucial requirements for
a model of PD, namely a selective loss of DAergic neurons,
together with detectable motor deficits. Nonetheless, in addition
to the classical features of PD, these models displayed different
patterns of NMS symptoms. Overall, the α-syn model proved
to be useful to study changes in exploratory activity, while the
PQ model offered a valuable approach to investigate neuropsy-
chiatric dysfunction, specifically alterations in depression and
anxiety-like behavior. Finally, the 6-OHDA model displayed the
broader spectrum of NMS and thus might be of use to study in
combination emotional and cognitive deficits associated to PD. In
future studies, the intrinsic differences of these toxin and genetic
models can be relevant to unravel the mechanism underlying
NMS, as well as to screen drugs for symptomatic treatment of the
disease.
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